21 completed, 5 unknown, 4 terminated, 3 recruiting. 36 Phase 1, 11 Phase 2.
Follow Cardiac Conduction System Disease: new trials by email Literature Review of Cardiac Conduction System Disease trials Research Report on Cardiac Conduction System Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ATR 1072 in Participants With PRKAG2 Syndrome ATR 1072 - Cardiac Glycogenosis, Cardiomyopathy | Phase 1 / Phase 2 | Recruiting | Atrium Therapeutics | 37 | 2026-09-14 | 2026-09-18 |
| A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) SGT-501 - Catecholaminergic Polymorphic Ventricular Tachycardia | Phase 1 | Recruiting | Solid Biosciences Inc. | 18 | 2026-02-23 | 2026-10-26 |
| To Observe Haemodynamic Parameters Including, Heart Rate, Blood Pressure, Respiratory Rate , and Oxygen Saturation, With or Without Giving Reversal Agent on Extubation, in Patients Receiving Single Shot of Atracurium , and to Observe Post Operative Residual Paralysis and Airway Reflexes in PACU. Placebo drug ( normal saline ), neostigmine (reversal agent) - Tachycardia, Hypertension | Phase 1 / Phase 2 | Completed | Ziauddin University | 100 | 2025-03-12 | 2025-07-31 |
| Study of LQT-1213 on QTc-induced Prolongation in Healthy Adult Subjects (Part1) and on Congenital Long QT in Patients Diagnosed With Type 2 or 3 Long QT Syndrome (Part 2). LQT-1213, Placebo, Dofetilide 250 μg Cap - Long QT Syndrome | Phase 1 / Phase 2 | Terminated | Thryv Therapeutics, Inc. | 42 | 2023-03-12 | 2025-07-24 |
| A Study of Etripamil in Healthy Subjects Etripamil Nasal Spray 70mg, Placebo - Healthy Chinese Subjects | Phase 1 | Completed | Corxel Pharmaceuticals | 12 | 2023-03-07 | 2023-04-10 |
| Phase 1 Study of LQT-1213 in Healthy Adults LQT-1213, Placebo - Long QT Syndrome | Phase 1 | Completed | Thryv Therapeutics, Inc. | 50 | 2022-09-14 | 2023-09-26 |
| Dose Escalation for SBRT of Recurrent VT Ventricular Tachyarrhythmia - a Single Center, Phase II Clinical Trial Dose escalating stereotactic arrhythmia radioablation to treat ventricular tachycardia (VT) - Ventricular Tachycardia | Phase 1 | Recruiting | University of Zurich | 15 | 2022-07-01 | 2026-08-21 |
| Percutaneous Inferior Cervical Sympathetic Block for Treatment of Refractory Ventricular Tachycardia Percutaneous inferior cervical sympathetic block - Ventricular Tachycardia | Phase 1 | Withdrawn | University of Missouri-Columbia | 2022-07-01 | 2023-08-07 | |
| SBRT in Chagas Disease Ventricular Tachycardia Stereotactic Body Radiation Therapy - Ventricular Tachycardia, Chagas Disease | Phase 1 / Phase 2 | Unknown | University of Sao Paulo General Hospital | 10 | 2021-07-14 | 2024-07-16 |
| Phase I/II Randomized Study of Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care for Refractory Structural Cardiac Arrhythmias (SABR-HEART) stereotactic ablative radiotherapy (SABR), Standard of Treatment - Cardiac Arrhythmia, Cardiac | Phase 1 / Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2019-09-12 | 2024-02-13 | |
| A Study to Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers AZD6094 200 mg, Placebo, Moxifloxacin - Solid Tumors | Phase 1 | Completed | AstraZeneca | 45 | 2017-09-06 | 2020-02-20 |
| Micra Atrial Tracking Using a Ventricular Accelerometer Study MARVEL algorithm - Atrioventricular Conduction Block | Phase 1 | Completed | Medtronic Cardiac Rhythm and Heart Failure | 70 | 2017-07-10 | 2018-10-26 |
| Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia stereotactic body radiotherapy (SBRT) - Ventricular Tachycardia, Cardiomyopathy | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 19 | 2016-07-01 | 2024-08-21 |
| Analysis of Adenosine on Sinus and Atrioventricular Nodal Conduction in the Pediatric Transplanted Heart Adenosine, Cardiac catheterization - Sinus Bradycardia, Atrioventricular Block | Phase 1 | Completed | Columbia University | 80 | 2015-07-01 | 2018-02-08 |
| Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Renal Function Eleclazine - Long QT Syndrome | Phase 1 | Completed | Gilead Sciences | 55 | 2015-05-01 | 2015-12-22 |
| Pharmacokinetics of Eleclazine in Adults With Normal and Impaired Hepatic Function Eleclazine - Long QT Syndrome | Phase 1 | Completed | Gilead Sciences | 49 | 2015-03-19 | 2019-07-29 |
| Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults GS-6615, Placebo to match GS-6615, Placebo to match dofetilide - Long QT Syndrome | Phase 1 | Completed | Gilead Sciences | 60 | 2015-02-01 | 2015-05-20 |
| Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers Moxifloxacin - Cardiac Toxicity | Phase 1 | Unknown | Haiyan Li | 80 | 2014-04-01 | 2014-04-21 |
| A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers Tramadol HCl, 50 mg, Placebo - Healthy | Phase 1 | Completed | Janssen Scientific Affairs, LLC | 30 | 2013-08-01 | 2014-12-16 |
| Botulinum Toxin Injection to Prevent Ventricular Arrhythmias Botulinum Toxin - Symptomatic Ventricular Asystolia, Ventricular Tachycardia | Phase 1 | Unknown | Meshalkin Research Institute of Pathology of Circulation | 30 | 2013-06-01 | 2015-09-25 |
Showing 20 of 36. Sign in to see all of them.
Long QT Syndrome (13) · Tachycardia, Ventricular (10) · Tachycardia (8) · Arrhythmias, Cardiac (4) · Postural Orthostatic Tachycardia Syndrome (3) · Atrioventricular Block (2) · Cardiomyopathies (2) · Death, Sudden, Cardiac (2) · Orthostatic Intolerance (2) · Pain (2) · Tachycardia, Supraventricular (2) · Agnosia (1) · Andersen Syndrome (1) · Atrial Fibrillation (1) · Cardiotoxicity (1)
Cardiovascular Diseases (36) · Heart Diseases (36) · Pathological Conditions, Signs and Symptoms (36) · Pathologic Processes (35) · Arrhythmias, Cardiac (32) · Cardiovascular Abnormalities (15) · Congenital Abnormalities (15) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (15) · Heart Defects, Congenital (15) · Tachycardia (11) · Signs and Symptoms (6) · Nervous System Diseases (4) · Neurologic Manifestations (4) · Autonomic Nervous System Diseases (3)
eleclazine (4) · Moxifloxacin (3) · Acetazolamide (2) · Radiosurgery (2) · Saline Solution (2) · Sodium Chloride (2) · dofetilide (2) · 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine (1) · Adenosine (1) · Atenolol (1) · Atomoxetine Hydrochloride (1) · Botulinum Toxins (1) · Capsules (1) · Cardiac Catheterization (1) · Catheter Ablation (1)
Gilead Sciences (4) · Thryv Therapeutics, Inc. (2) · Aalborg University Hospital (1) · Assistance Publique - Hôpitaux de Paris (1) · AstraZeneca (1) · Atrium Therapeutics (1) · Beth Israel Deaconess Medical Center (1) · Biosense Webster, Inc. (1) · Columbia University (1) · Corxel Pharmaceuticals (1) · Foundation for Atlanta Veterans Education and Research, Inc. (1) · Haiyan Li (1) · J. Uriach and Company (1) · Janssen Scientific Affairs, LLC (1) · M.D. Anderson Cancer Center (1)
United States (22) · Czechia (3) · Spain (3) · China (2) · Denmark (2) · France (2) · Romania (2) · Austria (1) · Belgium (1) · Brazil (1) · Canada (1) · Germany (1) · Italy (1) · Malaysia (1) · Moldova (1)
A. Maziar Zafari, M.D., Ph.D (1) · Asma Abdus Salam, Consultant anaesthesiology (1) · Beny Charbit, MD (1) · Brian McNabb, MD (1) · Eli Gang, MD (1) · Elizabeth Layug, MD (1) · Eric S Silver, MD (1) · Esther G Donado, PhD (1) · Haiyan Li, MD (1) · Italo Biaggioni, MD (1) · Jan Matousek, DO (1)
PMID 10492412, PMID 10793602, PMID 12717123, PMID 1356374, PMID 15911704, PMID 17893459, PMID 18547438, PMID 19099294, PMID 19687359, PMID 20576632, PMID 22091288, PMID 23372884, PMID 24002370, PMID 24227635, PMID 24495468, PMID 24606242, PMID 24666686, PMID 24721800, PMID 28450351, PMID 28800628, PMID 29261883, PMID 29758405, PMID 30573962, PMID 30586734, PMID 32673517, PMID 33400845, PMID 33733338, PMID 34667360, PMID 3605668, PMID 37139057, PMID 37941012, PMID 6161627, PMID 9366929, PMID 9793671, PMID 9797517
2014 (2), R01HL059459 (1), U10HD045986 (1), U54NS059065 (1), UL1TR000445 (1)